With a diverse population of around 128 million people and an internationally recognized COFEPRIS, Mexico’s regulatory agency, the country developed the health sector’s clinical and laboratory research thanks to new policies that improve effectiveness. However, there are several challenges for the future. On the one hand, Mexico must mitigate diseases such as cancer, obesity and diabetes while on the other, it must increase production of generic medicines and improve the relationship between public and private institutions.